Clinical trial
Effect of Helicobacter Pylori Treatment on Remission of Idiopathic Central Serous Chorioretinopathy (ICSCR)
NCT00817245 is registered in ClinicalTrials.gov with Tabriz University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Helicobacter Pylori Treatment on Remission of Idiopathic Central Serous Chorioretinopathy (ICSCR)
- Lead sponsor
- Tabriz University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- January 31, 2009
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.